| __timestamp | Catalyst Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4473654 | 15746000 |
| Thursday, January 1, 2015 | 8597010 | 13392000 |
| Friday, January 1, 2016 | 7910260 | 9290000 |
| Sunday, January 1, 2017 | 7304399 | 7672000 |
| Monday, January 1, 2018 | 15875961 | 15293000 |
| Tuesday, January 1, 2019 | 36881187 | 22648000 |
| Wednesday, January 1, 2020 | 44233754 | 21864000 |
| Friday, January 1, 2021 | 49628000 | 37318000 |
| Saturday, January 1, 2022 | 58183000 | 48130000 |
| Sunday, January 1, 2023 | 133710000 | 108146000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, Catalyst Pharmaceuticals, Inc. and Madrigal Pharmaceuticals, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Catalyst Pharmaceuticals saw a staggering increase of nearly 2,900% in SG&A expenses, peaking at approximately $133.7 million in 2023. This reflects their aggressive expansion and market penetration strategies. Meanwhile, Madrigal Pharmaceuticals, Inc. also experienced a significant rise, with their SG&A expenses growing by about 587% over the same period, reaching around $108.1 million in 2023. This growth underscores their commitment to innovation and development. These trends highlight the dynamic nature of the pharmaceutical industry, where strategic spending can be a key driver of success.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Xenon Pharmaceuticals Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights